STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Tempus AI SEC Filings

TEM NASDAQ

Welcome to our dedicated page for Tempus AI SEC filings (Ticker: TEM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Parsing Tempus AI’s disclosures can feel like wading through genomic data tables and privacy footnotes. The company’s 10-K details algorithm training costs, HIPAA compliance spending, and the revenue split between lab diagnostics and data subscriptions—facts buried deep in legal language. If you have ever searched “Tempus AI SEC filings explained simply” or wondered how to track “Tempus AI insider trading Form 4 transactions,” you know the challenge.

Stock Titan resolves it. Our platform delivers real-time alerts the moment a “Tempus AI quarterly earnings report 10-Q filing” or a sudden “Tempus AI 8-K material events explained” document hits EDGAR. AI-powered summaries translate every section, so understanding Tempus AI SEC documents with AI takes minutes, not hours. Need to spot leadership sentiment? We surface “Tempus AI Form 4 insider transactions real-time” alongside concise context. Looking at compensation? The “Tempus AI proxy statement executive compensation” highlights are pre-tagged.

Investors use these insights to gauge R&D intensity, evaluate data-licensing momentum, and monitor “Tempus AI executive stock transactions Form 4.” Whether you seek a “Tempus AI annual report 10-K simplified” overview or a single line item like cloud-hosting spend, our AI points you there. Key uses include:

  • Compare segment revenue across consecutive 10-Q reports
  • Track insider buying before product launches
  • Review risk-factor updates tied to evolving health-data regulations

Stop scrolling endless PDFs—get “Tempus AI earnings report filing analysis” in plain language, updated the instant Tempus AI posts.

Filing
Rhea-AI Summary

Tempus AI, Inc. insider Erik Phelps submitted a Form 144 notifying a proposed sale of 3,664 shares of Class A common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $287,440.80, and an approximate sale date of 08/19/2025. The filing shows those 3,664 shares were acquired as restricted stock units on 04/18/2023 (371 shares), 07/18/2023 (2,470 shares) and 05/02/2024 (823 shares), which sum to the shares offered for sale. The filing also discloses prior sales by the same person in the last three months: 8,415 shares sold on 05/20/2025 for $531,918.03 and 51,317 shares sold on 06/16/2025 for $3,723,602.63. The Form 144 includes the required certification that the seller is not aware of undisclosed material adverse information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Filing
Rhea-AI Summary

Tempus AI, Inc. (TEM) Form 144 shows proposed sale of 5,398 Class A common shares through Morgan Stanley Smith Barney LLC on 08/19/2025 with an aggregate market value of $423,473.10. The filing identifies the shares as originating from restricted stock units issued between 04/27/2022 and 05/02/2024 totaling 5,398 shares. Recent sales by the same person, Andrew Polovin, are disclosed: total sales of 9,797 shares on 05/20/2025 for $619,275.23, 10b5-1 sales of 7,755 shares on 05/20/2025 for $494,085.01, and 1,423 shares on 06/16/2025 for $102,640.99. The filer certifies no undisclosed material adverse information and notes potential use of a 10b5-1 plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Filing
Rhea-AI Summary

Tempus AI, Inc. (TEM) submitted a Form 144 disclosing a proposed sale of 17,460 Class A common shares through Morgan Stanley Smith Barney, with an aggregate market value of $1,369,737, and an approximate sale date of 08/19/2025 on NASDAQ. Those shares reflect restricted stock units acquired from the issuer on 01/03/2022 (1,746), 04/18/2023 (583), 07/18/2023 (5,820), and 08/01/2024 (9,311), totaling 17,460 shares. The filer also reported insider sales in the past three months totaling 32,820 shares for $2,040,116.11, including a 10b5-1 plan sale of 20,000 shares on 06/03/2025. The notice includes the required representation that the seller is not aware of undisclosed material adverse information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Filing
Rhea-AI Summary

Tempus AI, Inc. (TEM) filing a Form 144 notifies the market of a proposed sale of 17,458 Class A common shares through Morgan Stanley Smith Barney, with an aggregate market value reported as $1,369,580.10 and an approximate sale date of 08/19/2025 on Nasdaq. The shares were acquired as restricted stock units on 06/13/2024. The filing also lists prior sales in the past three months by related parties and individuals, including Eric P. Lefkofsky and entities Blue Media, LLC and Gray Media, LLC, totaling significant share volumes and gross proceeds across dates from 05/20/2025 to 07/28/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Filing
Rhea-AI Summary

Tempus AI, Inc. insider filings show a proposed sale of 7,528 Class A common shares through Morgan Stanley Smith Barney on NASDAQ, with an aggregate market value of $590,571.60. The shares were granted as restricted stock units between 04/21/2021 and 05/02/2024 in multiple tranches totaling the amounts listed. The filer previously sold 23,121 shares under a 10b5-1 plan on 05/20/2025 for gross proceeds of $1,462,779.51. The notice includes the standard signature representation that no undisclosed material adverse information is known.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Filing
Rhea-AI Summary

Tempus AI insider Ryan M. Bartolucci filed a Form 144 notifying intent to sell 1,904 shares of Class A common stock through Morgan Stanley Smith Barney LLC with an approximate aggregate market value of $149,368.80. The proposed sale date listed is 08/19/2025 and the issuer's outstanding shares are reported as 168,683,769.

The shares to be sold were issued as restricted stock units on four dates (07/14/2021, 04/27/2022, 04/18/2023 and 05/02/2024) totaling 1,904 shares. The filing also discloses a prior sale by the same person of 6,073 Class A shares on 05/20/2025 for gross proceeds of $384,022.79. The filer certifies no undisclosed material adverse information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Tempus AI's definitive information statement discloses amended articles with marked changes included as Appendix A-2 and references a securities description in Exhibit 4.3. The document shows a holder with 40,601,284 Class A shares (24.1%) and 5,043,789 Class B shares (100.0%) representing 60.0% combined voting power. The articles require a two-thirds plus one (66 2/3%) vote of outstanding voting power to alter Articles V, VI and VII.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
-
Filing
Rhea-AI Summary

Tempus AI, Inc. (TEM) submitted a Form 144 notice to report a proposed sale of 44,000 shares of common stock through Citigroup Global Markets Inc., with an aggregate market value of $3,075,786.12. The filing lists the approximate sale date as 08/13/2025 and the shares are expected to trade on NASDAQ. The shares were acquired on 01/30/2025 as a venture capital distribution from Revolution Growth III, totalling 130,756 shares received on that date. The filer reports no sales of the issuer's securities in the past three months. Certain filer identification fields (CIK/CCC and contact details) are not provided in the visible content.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Theodore J. Leonsis, a director of Tempus AI, Inc. (TEM), reported a sale of Class A common stock on 08/13/2025. The filing shows 44,000 shares disposed of at a reported price of $69.90 per share. After the transaction the report lists 86,756 shares held indirectly through the Theodore J. Leonsis Revocable Trust and 15,511 shares held directly by the reporting person. The form notes that certain shares were recharacterized following pro rata distributions by Revolution Growth GP III, LP, which changed the form of ownership but did not involve consideration. The filing was signed by an attorney-in-fact on 08/15/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Tempus AI, Inc. notified holders of record as of August 8, 2025 that stockholders holding a majority of voting power have approved amended and restated articles of incorporation by written consent. The Majority Holder beneficially owned 39,142,245 shares of Class A and 5,043,789 shares of Class B on the record date, representing approximately 59.5% of total voting power. Because the required consent was received, no additional stockholder vote or proxy solicitation will occur.

The Amended Articles add governance and corporate flexibility provisions: a waiver of jury trials for internal actions, an opt-out of a Nevada statutory limitation on distributions (NRS 78.288(2)(b)), and an opt-out of Nevada’s "combinations with interested stockholders" statutes (NRS 78.411–78.444). The Board approved the amendments and the actions will become effective at least 20 calendar days after mailing this Information Statement, after which the Company may file the Amended Articles with the Nevada Secretary of State.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.63%
Tags
proxy

FAQ

What is the current stock price of Tempus AI (TEM)?

The current stock price of Tempus AI (TEM) is $70.29 as of November 21, 2025.

What is the market cap of Tempus AI (TEM)?

The market cap of Tempus AI (TEM) is approximately 11.7B.
Tempus AI

NASDAQ:TEM

TEM Rankings

TEM Stock Data

11.69B
103.29M
41.83%
44.1%
14%
Health Information Services
Services-computer Programming, Data Processing, Etc.
Link
United States
CHICAGO